China's Innovent Biologics looks to raise up to $422 million in HK IPO, say sources: Reuters

Chinese biotech firm Innovent Biologics is looking to raise up to $422 million in its Hong Kong IPO, sources told Reuters, in what could be the biggest biotech IPO in the financial hub this year.